Tuesday, July 24, 2018 8:27:29 PM
“RavenQuest: An Undervalued Opportunity
Over the last month, RavenQuest Biomed Inc. (RQB.CN) (RVVQF) has been under considerable pressure and this decline makes the company a stock to watch. RavenQuest BioMed represents an attractive and differentiated Canadian cannabis company that is in the middle of a major growth cycle.
Ravenquest is in the middle of a major expansion and will be well positioned to capitalize on an undersupplied Canadian cannabis market. In October, Canada’s recreational marijuana market will open and this will create a major supply-demand issue. Ravenquest expects to be producing approx. 11,00 kilograms on an annual basis by the end of the year and will be able to capitalize on a market shortage.
The Canadian cannabis producer is led by a management team with a proven track record of success and who are recognized leaders in the cannabis industry. This is an important aspect of the story and we are confident in their ability to execute and create value for shareholders.
When compared to other Canadian cannabis producers, Ravenquest is very undervalued. The company has a multi-faceted growth strategy and we are favorable on this as it helps de-risk the business plan. We are favorable on the valuation and this is a stock that we will continue to monitor.”
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM